Manufacturer record

Gnosis Pharmaceuticals Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

10 batches manufactured by Gnosis Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between June 2023 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

10 records linked to Gnosis Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
10Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2023 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

10
NSQ batches since 2023
9
Products affected
Dissolution
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2023 · 12024 · 22025 · 32026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Telmisartan Tablets IP 80mg PT50022AMfg 2025-11 · Exp 2027-10 The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution SDTL, GuwahatiState lab Jun 2026
Ofloxacin And Ornidazole Tablet IP GT301348Mfg 2025-12 · Exp 2026-11 DescriptionDescription RDTL, Bellary, KarnatakaState lab Jun 2026
Cefpodoxime Proxetil & Potassium Clavulanate Oral Suspension BD400461AMfg 2025-03 · Exp 2026-08 Sample Tabonic CV Dry syrup does not comply assay for Cefpodoxime and Clavulanic acid as per STP.Assay DCL, TelanganaState lab Feb 2026
Pantoprazole Gastro resistant Tablets IP GT400378Mfg 2024-06 · Exp 2026-05 The sample does not conform to standard quality in respect of the test for Description and Dissolution in Buffer medium performed.Dissolution SDTL Govt. of Tripura, AgartalaState lab Jan 2026
Azithromycin Tablets IP (Aziventis-500 Tablets) GT400149Mfg 2024-04 · Exp 2026-03 Test for dissolution.Dissolution CDL, KolkataCDSCO lab Jul 2025
Ketoconazole Tablets I.P. 200mg GT301737Mfg 2024-03 · Exp 2026-02 Description onlyDescription State Lab KarnatakaState lab Apr 2025
Lignocaine Hydrochloride Gel IP 5 % w/v (30 g) G407Mfg 2024-09 · Exp 2026-08 "pH"pH CDTL MumbaiCDSCO lab Feb 2025
Lignocaine Hydrochloride Gel IP 5% w/v (30 g) G406Mfg 2024-09 · Exp 2026-08 pHpH CDL KolkataCDSCO lab Dec 2024
Paziva -40 GT300234Mfg 2023-05 · Exp 2025-04 It fails the test ?Dissolution? as per IPDissolution DTL ThiruvananthapuramState lab Aug 2024
Keraboost (Tablets of D-Biotin, N- Acetyl L-Cysteine, Vitamins & Minerals) GT200998Mfg 2022-09 · Exp 2024-08 Description and Assay of Calcium PantothenateAssay CDL KolkataCDSCO lab Jun 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.